Showing results (301-310 of 321) with videos related to
Sort By:
Pageof 33
American Heart Journal|December 5, 2009
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registryTelly A Meadows, Deepak L Bhatt, Alan T Hirsch, et al.American Heart Journal|December 17, 2016
Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) studyBharath Ambale Venkatesh, Victor Nauffal, Chikara Noda, et al.American Heart Journal|June 25, 2005
Development of a multicenter peripheral arterial interventional database: the PVD-QI2Debabrata Mukherjee, Khan Munir, Alan T Hirsch, et al.Cerebrovascular Diseases (Basel, Switzerland)|March 14, 2008
Risk factor profile and management of cerebrovascular patients in the REACH RegistryJoachim Röther, Mark J Alberts, Emmanuel Touzé, et al.American Heart Journal|December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cellsEmerson C Perin, Michael Murphy, John P Cooke, et al.Gene Therapy|December 10, 2015
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemiaM R Kibbe, A T Hirsch, F O Mendelsohn, et al.Nature Ecology & Evolution|June 10, 2025
Assessing coverage of the monitoring framework of the Kunming-Montreal Global Biodiversity Framework and opportunities to fill gapsF Affinito, S H M Butchart, E Nicholson, et al.JAMA|September 1, 2010
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosisDeepak L Bhatt, Kim A Eagle, E Magnus Ohman, et al.Journal of the American College of Cardiology|March 14, 2015
Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER studyTimothy P Murphy, Donald E Cutlip, Judith G Regensteiner, et al.Frontiers in Immunology|March 11, 2025
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADORegAndrea Forschner, Katharina C Kähler, Martin Gschnell, et al.Pageof 33